0
     

Report Added
Report already added
India Diabetes Care Market, By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, FY2026

India Diabetes Care Market, By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, FY2026

India diabetes care market was valued at USD1530.3 million in value terms in FY2020 and is forecast to grow at CAGR of 7.94% in value terms to reach USD2408.39 million by FY2026. India diabetes care market is witnessing consistent growth, owing to the increasing geriatric population, increasing diabetic population and the adoption of an unhealthy lifestyle leading to obesity that further increases the diabetic population. Moreover, factors such as advancing technology and increasing cost of living are continuously fueling the diabetes care market in India.

The diabetes care market is segmented based on Diabetes type, Product type, End User, Region, and Company. Based on product type, the market can be split into diabetes drug and diabetes care devices. Among these, the diabetes drug segment is expected to dominate the market during the forecast period owing to their widespread use for all diabetes type. Based on diabetes type, the market can be fragmented into diabetes type 1, diabetes type 2 and gestational diabetes. Here, the most prevalent diabetes type is type 1. Furthermore, the glucose monitoring devices segment is expected to exhibit the highest growth on account of increasing diabetic cases. The self-monitoring devices are still dominating the market because they are relatively easier to use and cheaper.

Novo Nordisk India Private Limited, Sanofi India Limited, Eli Lilly India Pvt. Ltd., Roche Diagnostics India Pvt Ltd., Abbott India Limited, Becton Dickinson Private Limited, Johnson & Johnson Private Limited, India Medtronic Pvt. Ltd., Ypsomed India Private Ltd. and Novartis India Ltd are some of the companies operating in the India diabetes care market.

Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
-bjective of the Study:
• To analyze the historical growth in the market size of India diabetes care market from FY2016 to FY2020.
• To estimate and forecast the market size of India diabetes care market from FY2021 to FY2026 and growth rate until FY2026.
• To classify and forecast India diabetes care market based on by product type, by diabetes type, by end use, company and region.
• To identify dominant region or segment in the India diabetes care market.
• To identify drivers and challenges for India diabetes care market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India diabetes care market.
• To conduct pricing analysis for India diabetes care market.
• To identify and analyze the profile of leading players operating in India diabetes care market.
• To identify key sustainable strategies adopted by market players in India diabetes care market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of India diabetes care market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Manufacturers, distributors and end users
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers.
• Organizations, forums, and alliances related to diabetes care.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, India diabetes care market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• India Diabetes Care Market, By Type
- Diabetes Care Devices
- Diabetes Drugs Market
• India Diabetes Care Market, By Diabetes Type
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
• India Diabetes Care Market, By End User
- Home Care Settings
- Hospitals
- Clinics
• India Diabetes Care Market, By Region
- North
- East
- West
- South

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in India diabetes care market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).
1. Product of Interest Introduction: Diabetes Care Market
2. Research Methodology
3. Impact of COVID-19 on India Diabetes Care Market
4. Executive Summary
5. Voice of Customers/Customer Insights
6. India Diabetes Care Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Diabetes Drugs vs. Diabetes Care Devices)
6.2.2. By Type of Diabetes (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
6.2.3. By End User (Home Care Settings, Hospitals, Clinics)
6.2.4. By Region (North, South, East, West)
6.2.5. By Company
6.3. Product Market Map
7. India Diabetes Care Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)
7.2.2. By Type of Diabetes
7.2.3. By End User
8. India Diabetes Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Insulin, Dipeptidyl peptidase-4 (DPP-4) inhibitors, Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists), Others (Sodium-glucose co-transporter-2 (SGLT2) inhibitors, Biguanides, Sulfonylureas))
8.2.2. By Type of Diabetes
8.2.3. By End User
9. Market Dynamics
9.1. Drivers/Opportunities
9.2. Challenges/Restraints
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. India Economic Profile
13. Competitive Landscape
13.1. Company Profiles (Top 10 companies including Diabetes Care Devices and Diabetes Drugs Market)
13.1.1. Novo Nordisk India Private Limited
13.1.2. Sanofi India Limited
13.1.3. Eli Lilly India Pvt. Ltd.
13.1.4. Roche Diagnostics India Pvt Ltd.
13.1.5. Abbott India Limited
13.1.6. Becton Dickinson Private Limited
13.1.7. Johnson & Johnson Private Limited
13.1.8. India Medtronic Pvt. Ltd.
13.1.9. Ypsomed India Private Ltd.
13.1.10. Novartis India Ltd.
14. Strategic Recommendations
15. About Us & Disclaimer

Kindly Fill The Form Below

Report Title: India Diabetes Care Market, By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, FY2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW